October is Breast Cancer Awareness Month, making it a timely opportunity for employers to review how 2026 breast cancer screening coverage requirements affect their group health plans.
U.S. employers project a median health care cost increase of 10% for 2027, according to Health Care Costs Pulse Survey: 2027 Cost Trend, a new survey from the International Foundation of Employee Benefit Plans.
Today’s blog addresses the question: Could medical marijuana and psychedelics soon be covered under employee benefit plans? Recent executive orders could impact health plan strategy and design.
Newly released International Foundation survey data revealed key trends for glucagon-like peptide-1 (GLP-1) drug coverage for U.S. corporate employers.
Employers should prepare now for expanded breast cancer screening and navigation coverage requirements applicable to group health plans in 2026, as the new requirements impact plan participants, administration and costs.
A new survey report from the International Foundation reveals increased U.S. employer spending on cancer/oncology care as well as common steerage techniques used to contain costs.
An estimated 60-70 million people in the U.S. are affected by digestive disease; addressing gut health among employees may have major impacts on plan costs as well as heath outcomes.
